{"name":"Dr Meru S","slug":"dr-meru-s","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPcDRLdGNFSXFWQkt4R3FWSndwckJ4em5iS1dIQk1Cai1Ud2ljUDFGczJCemNnZmVtNW1NX19JaHVlNHNOMEc5dUk0MkxiOVBvMnpWcm5lY3hOaGtnWlVJWlliVjI5X056d3hKM1dDbFU5OTBRWkM4SHZfcjh3cEZrcU94RFBQZFpSb1hBdU9WeUdNZ09ra2Y2Nk9nemhjVUk5TTZ1Y2todndFQ0JEWXRGMzVNc0FnWE51VzlrRk9KVVBOUQ?oc=5","date":"2026-03-15","type":"pipeline","source":"AD HOC NEWS","summary":"Merus NV Stock (ISIN: NL0011375928) Gains Momentum on Bispecific Antibody Pipeline Progress - AD HOC NEWS","headline":"Merus NV Stock (ISIN: NL0011375928) Gains Momentum on Bispecific Antibody Pipeline Progress","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxQYlNXOXJDTjVjOVBVb25Nc1RFRHpQclY3Z3VVejYzNm50cGRsUnRKeGZNSllXM3NSX0tMTmljaE1GYXU5eXByX1plVGxLTE9WNGJQTXlZZzZWZkJocENLcUdYUHNOOHNRcEp3cnRSMXNFU3dIR0JxWnhoTWE1Q2xrcGtOeFotMXdXZjVfWEFvQV9jTkxnWVJ2RTNVOEdreTFTczFndUEzb2lXLW5ZNHI0TXN2ZWtfQWhUakNQclJGc05GdHdxZ1BNSW8wekUwN0VUWWcxX0QtUV91SFZ4?oc=5","date":"2025-12-02","type":"pipeline","source":"Agency for Science, Technology and Research","summary":"Forget chasing the next Pfizer: Singapore’s biotech future lies in innovation, not giants - Agency for Science, Technology and Research","headline":"Forget chasing the next Pfizer: Singapore’s biotech future lies in innovation, not giants - Agency for Science, Technolo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPaV85TTVvelpjbFg2dGl3U1NYWGJIUl9wWExxSEIwTXNUbkpkeXNkQllvZWE2ZzZXTHNKdWpqQWdsSGZPVlpDUk9CdzhNd09raHhQYXQxXzBoVnd5UXVHbXFVUEZzTTlHdkJFaDg4RXdLTUcwU24wOWdaOFliRWxOOS1pNlp4UjlDR2N0Y3lzNm55cVZtQldBYzRucWd6d3pxLUVtN1VDbzg0d19wTE1qX2FKY09CNDhzbmNCcA?oc=5","date":"2025-11-17","type":"deal","source":"Contract Pharma","summary":"Merus, Halozyme Partner to Develop Subcutaneous Formulation of Petosemtamab - Contract Pharma","headline":"Merus, Halozyme Partner to Develop Subcutaneous Formulation of Petosemtamab","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNcW1qMFliZlhCQmtwOVM0UXlxNUdPc3R5RzVNVEZWVHFCbDYxbGU1RzZ3cVpfaTg1b1lWTnREVE1wQ3cxM3BfMDZuSWI0Z2NoZXpSV2JFZW1pOGNpc2M2UkZlQ1E1T2pHbll6bk5VTHo0aVlWRy0taTQ3MkNEcEIyTnQ0OVJyUWxhM1pKN1VoMFVQMGZGNnhveTN4VVNHRUhj?oc=5","date":"2025-10-29","type":"pipeline","source":"ascopost.com","summary":"Zenocutuzumab Potential Explored in NRG1 -Positive Cholangiocarcinoma - ascopost.com","headline":"Zenocutuzumab Potential Explored in NRG1 -Positive Cholangiocarcinoma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxNajRwVGs0T1V3aGs3bldGVTZhcjBuS2habDRVYlNINnBiVVV4RGEtbVlqTXQ1UEVqX0c2bFFDXzRBQzVMZHB4VXphVThaWlB6NG8xS3haeWtVZjRFVlZlU1FDcWxiYkstWHlHSE83a0RmU1NyZk41LTdfY3dvRF9rU0E5ZlJiWGRIRENVMV9YSFhVXy0yUkxyb1pSMW5qeWRBNVZiMU9aZVlnR1ROQVZyMWEzZHJBTEF5bmVfd0NiZUEyUWlURHhpNVpVMHJOc00?oc=5","date":"2025-09-29","type":"pipeline","source":"European Pharmaceutical Review","summary":"Genmab makes $8bn acquisition to boost late-stage antibody therapy pipeline | News - European Pharmaceutical Review","headline":"Genmab makes $8bn acquisition to boost late-stage antibody therapy pipeline | News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQd3JNTE5uR1ctMmUxeGZUengyMklLZUxPVUlId0tXU1BnV190amtwSzVMN1k1SmlNOVVrT1hNY1hvZHh2VlMzaGdfcjRJQUlNazFFM3J1bEktNEthRmZMWUFNc3NNWkxhZWxEVkpiSFpJYjRZeXJObEcybVEyYUJzNWQxaXE4QUhrWnpmSTJ4S291LW1rQVlIUU5DX0JOcENrU3RtbjRBSFA2ZnIwUGRHWUlQajQ4TFpKZzZJT05n?oc=5","date":"2025-09-29","type":"deal","source":"Reuters","summary":"Genmab to buy Dutch cancer drugmaker Merus for $8 billion - Reuters","headline":"Genmab to buy Dutch cancer drugmaker Merus for $8 billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQTWJYMVVncEt5bW9PSjFqd2lwVkUwdVBHS3k3dTNtWlgyNFM1aXhDd2M3eGhfVUlPNTI1emJ5UmNYSmxUX1JIYV8zQU5TZ1dDQ3UxeWRLM0MyNmwzX0JVdmc2TVJTbmVONVdLdnZaeG9Yamo2QWtfUHY0a1RndTBsQnJDQlUtTENMdFFLYTR6cHBRZDVwUGMzX0Jnb3REbDJya09rMkplUGFOUQ?oc=5","date":"2025-09-29","type":"trial","source":"Fierce Biotech","summary":"Genmab pays $8B to buy Merus and its phase 3 bispecific that wowed analysts - Fierce Biotech","headline":"Genmab pays $8B to buy Merus and its phase 3 bispecific that wowed analysts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOOWJ6ZDlwRW5LSE9Sb0FOYW9YNTFDWXJEbnp1Vm1aeUxHdjNoRTk3MWF1X3N0RTJtLURmVGZFbU92WVluWjVSRUtVSmZZQ2hUT0haRmpSb3dVQVJCcHA2TXBselRuaE5ubi1IeGRsWEM4T2NFdGUzcGJCNlNMMDAta1ZPWGJscU1TbFdvWkNtc3NVd29ISnc4YnROT19oMTNBZlIwOHA5TXJXUEVJbEFmSGI0ZHA?oc=5","date":"2025-09-29","type":"pipeline","source":"MedCity News","summary":"Genmab to Pay $8B to Get Its Hands on Merus Head & Neck Cancer Drug With Blockbuster Potential - MedCity News","headline":"Genmab to Pay $8B to Get Its Hands on Merus Head & Neck Cancer Drug With Blockbuster Potential","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTFB3UEk2dVlad1BMWjdSa016ZFlaZWtXT3h1VFh6Zkg3ak1KSXBHVGZWbzBUdmd1Tk5ILWRBMW1kc2UzMTMtbGduMjFQOWNZUVJYbXFINS0xVlAzcHBXMFAxSXRsam5yT3lqcmZ4enFHVV94WmtfVWZEeUhQbUE?oc=5","date":"2025-09-29","type":"deal","source":"Barron's","summary":"This Dutch Drugmaker’s Stock Is Jumping 38%. Here’s Why It’s Being Acquired. - Barron's","headline":"This Dutch Drugmaker’s Stock Is Jumping 38%. Here’s Why It’s Being Acquired. - Barron's","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNRDBrR3JKQW5oTTRudmVqQ3FZWW1wWlFCb2YyTzNicWZLNktqbVhoc0JNYUxVVDZWdzNHVFZtV1VPalMtSG1oN1hMeEFHQzRyNmc3Sl9YVnRKX0ZKTnNHTU5xOEFxaHdNMHMwX0xLN3pSVHA3Y0ZVS254cHo2S3BkTDRaUTBYb0w0azJlMU14bDRBeHFGbkFocw?oc=5","date":"2025-09-29","type":"pipeline","source":"The Pharma Letter","summary":"Genmab to expand pipeline with Merus acquisition - The Pharma Letter","headline":"Genmab to expand pipeline with Merus acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNMGNya0JjR2JTQWYyRGF2dTlmUy1tcXJETk80R0RLSjBrUW9wZHdJeU5wVUJNbV83eWt2MjE4dUExcWd1OUNZaEpIMUZNa05uaFc5dXpTLWY2c2VpbUg1SnVaWFJjci1ZM2dqSnJ0aURFSm53R3FpQkpKWHI5TVl4SW5UQVB1d2VOOVNFa1dUV3Z4RWN1Znk0ckh4RkhnZXVqM2J4UXBmRlNGcWM?oc=5","date":"2025-06-15","type":"pipeline","source":"MedCity News","summary":"ASCO 2025 Recap: Rise of the Bispecifics, Dueling Degraders, ADCs of Interest & More - MedCity News","headline":"ASCO 2025 Recap: Rise of the Bispecifics, Dueling Degraders, ADCs of Interest & More","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE5UbTdEV18tNFJrMEJ3VnpkV1djazZXcEppT2FNSktIcnhBYmpjYTc1ZUMwRS1MRW9XcFRFMm5EN3JsQUh4eVlicFFlbUEtM2prOWQ4a0pWZmpxc05jcmJQUXhtaFUwbGY1WV9fUlNEd1lscUZO?oc=5","date":"2025-05-09","type":"pipeline","source":"Yahoo Finance","summary":"Merus N.V. (MRUS): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Yahoo Finance","headline":"Merus N.V. (MRUS): Among the Best Cancer Stocks to Invest in for Long-Term Gain","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}